StoneX Group Inc. Purchases 2,201 Shares of UnitedHealth Group Incorporated $UNH

StoneX Group Inc. lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 29.1% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,761 shares of the healthcare conglomerate’s stock after purchasing an additional 2,201 shares during the quarter. StoneX Group Inc.’s holdings in UnitedHealth Group were worth $3,045,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. LFA Lugano Financial Advisors SA acquired a new position in UnitedHealth Group in the second quarter worth about $25,000. Bayforest Capital Ltd raised its holdings in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 48 shares in the last quarter. Islay Capital Management LLC acquired a new stake in UnitedHealth Group in the 2nd quarter valued at $31,000. Clal Insurance Enterprises Holdings Ltd raised its stake in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 50 shares in the last quarter. Finally, Kilter Group LLC acquired a new stake in shares of UnitedHealth Group in the 2nd quarter valued at $34,000. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on UNH shares. Truist Financial raised their price target on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a report on Tuesday, September 9th. Zacks Research upgraded shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. Piper Sandler reduced their price target on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 28th. Morgan Stanley boosted their target price on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research note on Friday, September 12th. Finally, Leerink Partners set a $410.00 target price on UnitedHealth Group and gave the stock an “outperform” rating in a report on Wednesday, October 29th. Seventeen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $385.54.

Read Our Latest Research Report on UNH

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $330.61 on Friday. The company has a market capitalization of $299.48 billion, a price-to-earnings ratio of 17.26, a PEG ratio of 2.16 and a beta of 0.43. The company has a 50-day simple moving average of $341.79 and a 200 day simple moving average of $315.89. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $606.36.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The firm had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business’s revenue was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $7.15 EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.